Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia

Por um escritor misterioso

Descrição

Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Inhibitors of the Menin-Mixed Lineage Leukemia (MLL) Interaction
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
High-Affinity Small-Molecule Inhibitors of the Menin-Mixed Lineage
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Targeting the undruggable: menin inhibitors ante portas
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Structure-Based Discovery of M-89 as a Highly Potent Inhibitor of
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Designed to kill: novel menin-MLL inhibitors target MLL-rearranged
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
A molecular switch between mammalian MLL complexes dictates
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
RCSB PDB - 4GQ6: Human menin in complex with MLL peptide
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Molecular mechanisms of MLL-associated leukemia
de por adulto (o preço varia de acordo com o tamanho do grupo)